Difference between revisions of "Template:Antithrombotics"

From blackwiki
Jump to navigation Jump to search
blackwiki>Lukashenk0
m
Line 22: Line 22:
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
 
| group2 = [[P2Y12|ADP receptor/P2Y<sub>12</sub>]] [[Adenosine diphosphate receptor inhibitor|inhibitors]]
 
|  list2 =
 
|  list2 =
* ''[[thienopyridine]]s''
+
* [[Thienopyridine]]s
 
** [[Clopidogrel]]
 
** [[Clopidogrel]]
 
** [[Prasugrel]]
 
** [[Prasugrel]]
 
** [[Ticlopidine]]
 
** [[Ticlopidine]]
* ''[[nucleotide]]/[[nucleoside]] analogs''
+
* [[Nucleotide]]/[[nucleoside]] analogs
 
** [[Cangrelor]]
 
** [[Cangrelor]]
 
** [[Elinogrel]]
 
** [[Elinogrel]]
Line 48: Line 48:
 
| group5 = [[Thromboxane inhibitors]]
 
| group5 = [[Thromboxane inhibitors]]
 
|  list5 =
 
|  list5 =
* ''[[thromboxane synthase inhibitors]]''
+
* [[Thromboxane synthase inhibitors]]
 
** [[Dipyridamole]] ([[Acetylsalicylic acid/dipyridamole|+Aspirin]])
 
** [[Dipyridamole]] ([[Acetylsalicylic acid/dipyridamole|+Aspirin]])
 
** [[Picotamide]]
 
** [[Picotamide]]
* ''[[Thromboxane receptor antagonist|receptor antagonist]]''
+
* [[Thromboxane receptor antagonist|Receptor antagonist]]s
 
** [[Terutroban]]<sup>†</sup>
 
** [[Terutroban]]<sup>†</sup>
  
Line 74: Line 74:
 
   | group2 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
 
   | group2 = [[Vitamin K antagonist]]s<br />(inhibit [[Thrombin|II]], [[Factor VII|VII]], [[Factor IX|IX]], [[Factor X|X]])
 
   |  list2 =
 
   |  list2 =
* ''[[coumarin]]s:'' [[Acenocoumarol]]
+
* [[Coumarin]]s: [[Acenocoumarol]]
 
* [[Coumatetralyl]]
 
* [[Coumatetralyl]]
 
* [[Dicoumarol]]
 
* [[Dicoumarol]]
Line 80: Line 80:
 
* [[Phenprocoumon]]
 
* [[Phenprocoumon]]
 
* [[Warfarin]]<sup>#</sup>
 
* [[Warfarin]]<sup>#</sup>
*''[[1,3-Indandione]]s:'' [[Clorindione]]
+
* [[1,3-Indandione]]s: [[Clorindione]]
 
* [[Diphenadione]]
 
* [[Diphenadione]]
 
* [[Phenindione]]
 
* [[Phenindione]]
* ''other:'' [[Tioclomarol]]
+
* Other: [[Tioclomarol]]
  
 
| group3 = [[Factor Xa]] inhibitors<br />(with some II inhibition)
 
| group3 = [[Factor Xa]] inhibitors<br />(with some II inhibition)
Line 91: Line 91:
 
| group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
 
| group1 = [[Heparin]] group/<br />[[glycosaminoglycan]]s/<br />(bind [[antithrombin]])
 
| list1  =
 
| list1  =
* ''[[low molecular weight heparin]]''
+
* [[Low molecular weight heparin]]
 
** [[Bemiparin sodium|Bemiparin]]
 
** [[Bemiparin sodium|Bemiparin]]
 
** [[Certoparin sodium|Certoparin]]
 
** [[Certoparin sodium|Certoparin]]
Line 100: Line 100:
 
** [[Reviparin sodium|Reviparin]]
 
** [[Reviparin sodium|Reviparin]]
 
** [[Tinzaparin sodium|Tinzaparin]]
 
** [[Tinzaparin sodium|Tinzaparin]]
* ''[[oligosaccharide]]s''
+
* [[Oligosaccharide]]s
 
** [[Fondaparinux]]
 
** [[Fondaparinux]]
 
** [[Idraparinux]]
 
** [[Idraparinux]]
* ''[[heparinoid]]''
+
* [[Heparinoid]]s
 
** [[Danaparoid]]
 
** [[Danaparoid]]
 
** [[Dermatan sulfate]]
 
** [[Dermatan sulfate]]
Line 110: Line 110:
 
| group2 = [[Direct Xa inhibitor]]s
 
| group2 = [[Direct Xa inhibitor]]s
 
|  list2 =
 
|  list2 =
* ''xabans''
+
* Xabans
 
** [[Apixaban]]
 
** [[Apixaban]]
 
** [[Betrixaban]]
 
** [[Betrixaban]]
Line 121: Line 121:
 
| group5 = [[Direct thrombin inhibitor|Direct thrombin (IIa) inhibitor]]s
 
| group5 = [[Direct thrombin inhibitor|Direct thrombin (IIa) inhibitor]]s
 
|  list5 =
 
|  list5 =
* ''[[Direct_thrombin_inhibitor#Bivalent|bivalent]]:'' [[Hirudin]]
+
* [[Direct_thrombin_inhibitor#Bivalent|Bivalent]]: [[Hirudin]]
 
** [[Bivalirudin]]
 
** [[Bivalirudin]]
 
** [[Desirudin]]
 
** [[Desirudin]]
 
** [[Lepirudin]]
 
** [[Lepirudin]]
* ''[[Direct_thrombin_inhibitor#Univalent|univalent]]:'' [[Argatroban]]
+
* [[Direct_thrombin_inhibitor#Univalent|Univalent]]: [[Argatroban]]
 
* [[Dabigatran]]
 
* [[Dabigatran]]
 
* [[Melagatran]]<sup>‡</sup>
 
* [[Melagatran]]<sup>‡</sup>
Line 142: Line 142:
 
| group3 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
 
| group3 = [[Thrombolytic drug]]s/<br />[[fibrinolytic]]s
 
|  list3 =
 
|  list3 =
* ''[[plasminogen activator]]s:'' ''[[recombinant tissue plasminogen activators|r-tPA]]''
+
* [[Plasminogen activator]]s: [[recombinant tissue plasminogen activators|r-tPA]]
 
** [[Tissue plasminogen activator|Alteplase]]
 
** [[Tissue plasminogen activator|Alteplase]]
 
** [[Reteplase]]
 
** [[Reteplase]]
 
** [[Tenecteplase]]
 
** [[Tenecteplase]]
* ''UPA''
+
* UPA
 
** [[Saruplase]]
 
** [[Saruplase]]
 
** [[Urokinase]]
 
** [[Urokinase]]
Line 152: Line 152:
 
* [[Monteplase]]
 
* [[Monteplase]]
 
* [[Streptokinase]]<sup>#</sup>
 
* [[Streptokinase]]<sup>#</sup>
*''other [[serine endopeptidase]]s:'' [[Ancrod]]
+
*Other [[serine endopeptidase]]s: [[Ancrod]]
 
* [[Brinase]]
 
* [[Brinase]]
 
* [[Fibrinolysin]]
 
* [[Fibrinolysin]]

Revision as of 22:56, 7 December 2014

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Antithrombotics|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Antithrombotics|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Antithrombotics|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.